These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 36472051)

  • 1. Interaction between sarcopenia and nonalcoholic fatty liver disease.
    Joo SK; Kim W
    Clin Mol Hepatol; 2023 Feb; 29(Suppl):S68-S78. PubMed ID: 36472051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011).
    Lee YH; Kim SU; Song K; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH
    Hepatology; 2016 Mar; 63(3):776-86. PubMed ID: 26638128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What Does Sarcopenia Have to Do with Nonalcoholic Fatty Liver Disease?
    Ferenc K; Jarmakiewicz-Czaja S; Filip R
    Life (Basel); 2023 Dec; 14(1):. PubMed ID: 38255652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis.
    Bhanji RA; Narayanan P; Allen AM; Malhi H; Watt KD
    Hepatology; 2017 Dec; 66(6):2055-2065. PubMed ID: 28777879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA.
    Wijarnpreecha K; Kim D; Raymond P; Scribani M; Ahmed A
    Eur J Gastroenterol Hepatol; 2019 Sep; 31(9):1121-1128. PubMed ID: 30888971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing Muscle-Liver Crosstalk to Treat Nonalcoholic Steatohepatitis.
    Chakravarthy MV; Siddiqui MS; Forsgren MF; Sanyal AJ
    Front Endocrinol (Lausanne); 2020; 11():592373. PubMed ID: 33424768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinics in Liver Disease: Update on Nonalcoholic Steatohepatitis: Sarcopenia and Nonalcoholic Fatty Liver Disease.
    Kawaguchi T; Takahashi H; Gerber LH
    Clin Liver Dis; 2023 May; 27(2):275-286. PubMed ID: 37024207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease.
    Polyzos SA; Vachliotis ID; Mantzoros CS
    Metabolism; 2023 Oct; 147():155676. PubMed ID: 37544590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lean nonalcoholic fatty liver disease and sarcopenia.
    Chen M; Cao Y; Ji G; Zhang L
    Front Endocrinol (Lausanne); 2023; 14():1217249. PubMed ID: 37424859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.
    Koo BK; Kim D; Joo SK; Kim JH; Chang MS; Kim BG; Lee KL; Kim W
    J Hepatol; 2017 Jan; 66(1):123-131. PubMed ID: 27599824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution.
    Alferink LJM; Trajanoska K; Erler NS; Schoufour JD; de Knegt RJ; Ikram MA; Janssen HLA; Franco OH; Metselaar HJ; Rivadeneira F; Darwish Murad S
    J Bone Miner Res; 2019 Jul; 34(7):1254-1263. PubMed ID: 31074909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease and sarcopenia: pathophysiological connections and therapeutic implications.
    Fernández-Mincone T; Contreras-Briceño F; Espinosa-Ramírez M; García-Valdés P; López-Fuenzalida A; Riquelme A; Arab JP; Cabrera D; Arrese M; Barrera F
    Expert Rev Gastroenterol Hepatol; 2020 Dec; 14(12):1141-1157. PubMed ID: 32811209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Common Mechanisms of Sarcopenia and NAFLD.
    Zhai Y; Xiao Q
    Biomed Res Int; 2017; 2017():6297651. PubMed ID: 29387723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcopenia Contributes to the Progression of Nonalcoholic Fatty Liver Disease- Related Fibrosis: A Meta-Analysis.
    Pan X; Han Y; Zou T; Zhu G; Xu K; Zheng J; Zheng M; Cheng X
    Dig Dis; 2018; 36(6):427-436. PubMed ID: 30048963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Cai C; Song X; Chen Y; Chen X; Yu C
    Hepatol Int; 2020 Jan; 14(1):115-126. PubMed ID: 31290072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on the relationship between non-alcoholic fatty liver disease and sarcopenia in type 2 diabetes mellitus].
    Jiang H; Cheng QF; Zhu BZ; Yang Q
    Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):977-982. PubMed ID: 34814392
    [No Abstract]   [Full Text] [Related]  

  • 17. Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?
    Mikolasevic I; Pavic T; Kanizaj TF; Bender DV; Domislovic V; Krznaric Z
    Can J Gastroenterol Hepatol; 2020; 2020():8859719. PubMed ID: 33204675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic fatty liver disease and sarcopenia is associated with the risk of albuminuria independent of insulin resistance, and obesity.
    Han E; Kim MK; Im SS; Jang BK; Kim HS
    J Diabetes Complications; 2022 Aug; 36(8):108253. PubMed ID: 35817677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcopenia and fatty liver disease.
    Kim JA; Choi KM
    Hepatol Int; 2019 Nov; 13(6):674-687. PubMed ID: 31705444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcopenia in patients with non-alcoholic fatty liver disease: is it a clinically significant entity?
    De Fré CH; De Fré MA; Kwanten WJ; Op de Beeck BJ; Van Gaal LF; Francque SM
    Obes Rev; 2019 Feb; 20(2):353-363. PubMed ID: 30474288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.